Prevots DR - Search Results

1

CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011-2018.

Ricotta EE, Prevots DR, Olivier KN. Ricotta EE, et al. Among authors: prevots dr. ERJ Open Res. 2022 Apr 11;8(2):00724-2021. doi: 10.1183/23120541.00724-2021. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35415188 Free PMC article.

2

Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs.

Ballarino GJ, Olivier KN, Claypool RJ, Holland SM, Prevots DR. Ballarino GJ, et al. Among authors: prevots dr. Respir Med. 2009 Oct;103(10):1448-55. doi: 10.1016/j.rmed.2009.04.026. Epub 2009 May 21. Respir Med. 2009. PMID: 19467851 Free PMC article.

3

Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005.

Billinger ME, Olivier KN, Viboud C, de Oca RM, Steiner C, Holland SM, Prevots DR. Billinger ME, et al. Among authors: prevots dr. Emerg Infect Dis. 2009 Oct;15(10):1562-9. doi: 10.3201/eid1510.090196. Emerg Infect Dis. 2009. PMID: 19861046 Free PMC article.

4

Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006.

Seitz AE, Olivier KN, Steiner CA, Montes de Oca R, Holland SM, Prevots DR. Seitz AE, et al. Among authors: prevots dr. Chest. 2010 Oct;138(4):944-9. doi: 10.1378/chest.10-0099. Epub 2010 Apr 30. Chest. 2010. PMID: 20435655 Free PMC article.

5

Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, Olivier KN. Prevots DR, et al. Am J Respir Crit Care Med. 2010 Oct 1;182(7):970-6. doi: 10.1164/rccm.201002-0310OC. Epub 2010 Jun 10. Am J Respir Crit Care Med. 2010. PMID: 20538958 Free PMC article.

6

Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007.

Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots DR. Seitz AE, et al. Among authors: prevots dr. Chest. 2012 Aug;142(2):432-439. doi: 10.1378/chest.11-2209. Chest. 2012. PMID: 22302301 Free PMC article.

7

Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.

Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Adjemian J, et al. Among authors: prevots dr. Am J Respir Crit Care Med. 2012 Apr 15;185(8):881-6. doi: 10.1164/rccm.201111-2016OC. Epub 2012 Feb 3. Am J Respir Crit Care Med. 2012. PMID: 22312016 Free PMC article.

8

Spatial clusters of nontuberculous mycobacterial lung disease in the United States.

Adjemian J, Olivier KN, Seitz AE, Falkinham JO 3rd, Holland SM, Prevots DR. Adjemian J, et al. Among authors: prevots dr. Am J Respir Crit Care Med. 2012 Sep 15;186(6):553-8. doi: 10.1164/rccm.201205-0913OC. Epub 2012 Jul 5. Am J Respir Crit Care Med. 2012. PMID: 22773732 Free PMC article.

9

Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.

Binder AM, Adjemian J, Olivier KN, Prevots DR. Binder AM, et al. Among authors: prevots dr. Am J Respir Crit Care Med. 2013 Oct 1;188(7):807-12. doi: 10.1164/rccm.201307-1200OC. Am J Respir Crit Care Med. 2013. PMID: 23927602 Free PMC article.

10

Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease.

Olivier KN, Shaw PA, Glaser TS, Bhattacharyya D, Fleshner M, Brewer CC, Zalewski CK, Folio LR, Siegelman JR, Shallom S, Park IK, Sampaio EP, Zelazny AM, Holland SM, Prevots DR. Olivier KN, et al. Among authors: prevots dr. Ann Am Thorac Soc. 2014 Jan;11(1):30-5. doi: 10.1513/AnnalsATS.201307-231OC. Ann Am Thorac Soc. 2014. PMID: 24460437 Free PMC article.

11

Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk.

Adjemian J, Olivier KN, Prevots DR. Adjemian J, et al. Among authors: prevots dr. Am J Respir Crit Care Med. 2014 Sep 1;190(5):581-6. doi: 10.1164/rccm.201405-0884OC. Am J Respir Crit Care Med. 2014. PMID: 25068291 Free PMC article.

12

Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population.

Prevots DR, Adjemian J, Fernandez AG, Knowles MR, Olivier KN. Prevots DR, et al. Ann Am Thorac Soc. 2014 Sep;11(7):1032-8. doi: 10.1513/AnnalsATS.201404-184OC. Ann Am Thorac Soc. 2014. PMID: 25068620 Free PMC article.

13

The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease.

Winthrop KL, Ku JH, Marras TK, Griffith DE, Daley CL, Olivier KN, Aksamit TR, Varley CD, Mackey K, Prevots DR. Winthrop KL, et al. Among authors: prevots dr. Eur Respir J. 2015 Apr;45(4):1177-9. doi: 10.1183/09031936.00169114. Epub 2015 Jan 22. Eur Respir J. 2015. PMID: 25614169 Free PMC article. No abstract available.

14

Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.

Szymanski EP, Leung JM, Fowler CJ, Haney C, Hsu AP, Chen F, Duggal P, Oler AJ, McCormack R, Podack E, Drummond RA, Lionakis MS, Browne SK, Prevots DR, Knowles M, Cutting G, Liu X, Devine SE, Fraser CM, Tettelin H, Olivier KN, Holland SM. Szymanski EP, et al. Among authors: prevots dr. Am J Respir Crit Care Med. 2015 Sep 1;192(5):618-28. doi: 10.1164/rccm.201502-0387OC. Am J Respir Crit Care Med. 2015. PMID: 26038974 Free PMC article.

15

Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease.

Griffith DE, Adjemian J, Brown-Elliott BA, Philley JV, Prevots DR, Gaston C, Olivier KN, Wallace RJ Jr. Griffith DE, et al. Among authors: prevots dr. Am J Respir Crit Care Med. 2015 Sep 15;192(6):754-60. doi: 10.1164/rccm.201503-0444OC. Am J Respir Crit Care Med. 2015. PMID: 26068042 Free PMC article.

16

Clonal Diversification and Changes in Lipid Traits and Colony Morphology in Mycobacterium abscessus Clinical Isolates.

Park IK, Hsu AP, Tettelin H, Shallom SJ, Drake SK, Ding L, Wu UI, Adamo N, Prevots DR, Olivier KN, Holland SM, Sampaio EP, Zelazny AM. Park IK, et al. Among authors: prevots dr. J Clin Microbiol. 2015 Nov;53(11):3438-47. doi: 10.1128/JCM.02015-15. Epub 2015 Aug 19. J Clin Microbiol. 2015. PMID: 26292297 Free PMC article.

17

Beyond Marfan: the clinical impact of bronchiectasis and non-tuberculous mycobacteria in connective tissue diseases.

Leung JM, Olivier KN, Prevots DR, McDonnell NB. Leung JM, et al. Among authors: prevots dr. Int J Tuberc Lung Dis. 2015 Nov;19(11):1409. doi: 10.5588/ijtld.15.0597. Int J Tuberc Lung Dis. 2015. PMID: 26467599 Free PMC article. No abstract available.

18

Reply: Cure Not Possible, by Definition.

Griffith DE, Adjemian J, Brown-Elliott BA, Prevots DR, Philley JV, Olivier KN, Wallace RJ Jr. Griffith DE, et al. Among authors: prevots dr. Am J Respir Crit Care Med. 2015 Nov 15;192(10):1256-7. doi: 10.1164/rccm.201508-1515LE. Am J Respir Crit Care Med. 2015. PMID: 26568244 Free PMC article. No abstract available.

19

Mortality among patients with pulmonary non-tuberculous mycobacteria disease.

Fleshner M, Olivier KN, Shaw PA, Adjemian J, Strollo S, Claypool RJ, Folio L, Zelazny A, Holland SM, Prevots DR. Fleshner M, et al. Among authors: prevots dr. Int J Tuberc Lung Dis. 2016 May;20(5):582-7. doi: 10.5588/ijtld.15.0807. Int J Tuberc Lung Dis. 2016. PMID: 27084809 Free PMC article.

20

Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report.

Henkle E, Aksamit T, Barker A, Daley CL, Griffith D, Leitman P, Leitman A, Malanga E, Marras TK, Olivier KN, Prevots DR, Prieto D, Quittner AL, Skach W, Walsh JW, Winthrop KL; NTMRC Patient Advisory Panel. Henkle E, et al. Among authors: prevots dr. Ann Am Thorac Soc. 2016 Sep;13(9):S379-84. doi: 10.1513/AnnalsATS.201605-387WS. Ann Am Thorac Soc. 2016. PMID: 27627485 Free PMC article.

21

Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA.

Adjemian J, Frankland TB, Daida YG, Honda JR, Olivier KN, Zelazny A, Honda S, Prevots DR. Adjemian J, et al. Among authors: prevots dr. Emerg Infect Dis. 2017 Mar;23(3):439-447. doi: 10.3201/eid2303.161827. Emerg Infect Dis. 2017. PMID: 28221128 Free PMC article.

22

Geographic Distribution of Nontuberculous Mycobacterial Species Identified among Clinical Isolates in the United States, 2009-2013.

Spaulding AB, Lai YL, Zelazny AM, Olivier KN, Kadri SS, Prevots DR, Adjemian J. Spaulding AB, et al. Among authors: prevots dr. Ann Am Thorac Soc. 2017 Nov;14(11):1655-1661. doi: 10.1513/AnnalsATS.201611-860OC. Ann Am Thorac Soc. 2017. PMID: 28817307 Free PMC article.

23

Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.

Adjemian J, Olivier KN, Prevots DR. Adjemian J, et al. Among authors: prevots dr. Ann Am Thorac Soc. 2018 Jul;15(7):817-826. doi: 10.1513/AnnalsATS.201709-727OC. Ann Am Thorac Soc. 2018. PMID: 29897781 Free PMC article.

24

Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents.

Kadri SS, Adjemian J, Lai YL, Spaulding AB, Ricotta E, Prevots DR, Palmore TN, Rhee C, Klompas M, Dekker JP, Powers JH 3rd, Suffredini AF, Hooper DC, Fridkin S, Danner RL; National Institutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH–ARORI). Kadri SS, et al. Among authors: prevots dr. Clin Infect Dis. 2018 Nov 28;67(12):1803-1814. doi: 10.1093/cid/ciy378. Clin Infect Dis. 2018. PMID: 30052813 Free PMC article.

25

Epidemiology of Nontuberculous Mycobacteriosis.

Adjemian J, Daniel-Wayman S, Ricotta E, Prevots DR. Adjemian J, et al. Among authors: prevots dr. Semin Respir Crit Care Med. 2018 Jun;39(3):325-335. doi: 10.1055/s-0038-1651491. Epub 2018 Aug 2. Semin Respir Crit Care Med. 2018. PMID: 30071547 Free PMC article. Review.

26

Sarcoidosis-associated Hospitalizations in the United States, 2002 to 2012.

Wills AB, Adjemian J, Fontana JR, Steiner CA, Daniel-Wayman S, Olivier KN, Prevots DR. Wills AB, et al. Among authors: prevots dr. Ann Am Thorac Soc. 2018 Dec;15(12):1490-1493. doi: 10.1513/AnnalsATS.201806-401RL. Ann Am Thorac Soc. 2018. PMID: 30199648 Free PMC article. No abstract available.

27

Hospital-based antibiotic use in patients with Mycobacterium avium complex.

Ricotta EE, Olivier KN, Lai YL, Prevots DR, Adjemian J. Ricotta EE, et al. Among authors: prevots dr. ERJ Open Res. 2018 Nov 2;4(4):00109-2018. doi: 10.1183/23120541.00109-2018. eCollection 2018 Oct. ERJ Open Res. 2018. PMID: 30402451 Free PMC article.

28

Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.

Daniel-Wayman S, Abate G, Barber DL, Bermudez LE, Coler RN, Cynamon MH, Daley CL, Davidson RM, Dick T, Floto RA, Henkle E, Holland SM, Jackson M, Lee RE, Nuermberger EL, Olivier KN, Ordway DJ, Prevots DR, Sacchettini JC, Salfinger M, Sassetti CM, Sizemore CF, Winthrop KL, Zelazny AM. Daniel-Wayman S, et al. Among authors: prevots dr. Am J Respir Crit Care Med. 2019 Apr 15;199(8):947-951. doi: 10.1164/rccm.201807-1273PP. Am J Respir Crit Care Med. 2019. PMID: 30428263 Free PMC article. No abstract available.

29

Amikacin exposure and susceptibility of macrolide-resistant Mycobacterium abscessus.

Daniel-Wayman S, Shallom S, Azeem N, Olivier KN, Zelazny AM, Prevots DR. Daniel-Wayman S, et al. Among authors: prevots dr. ERJ Open Res. 2019 May 10;5(2):00154-2018. doi: 10.1183/23120541.00154-2018. eCollection 2019 Apr. ERJ Open Res. 2019. PMID: 31149626 Free PMC article.

30

Invasive Candidiasis Species Distribution and Trends, United States, 2009-2017.

Ricotta EE, Lai YL, Babiker A, Strich JR, Kadri SS, Lionakis MS, Prevots DR, Adjemian J. Ricotta EE, et al. Among authors: prevots dr. J Infect Dis. 2021 Apr 8;223(7):1295-1302. doi: 10.1093/infdis/jiaa502. J Infect Dis. 2021. PMID: 32798221 Free PMC article.

31

Mycobacterial Testing Trends, United States, 2009-2015¹.

Dean SG, Ricotta EE, Fintzi J, Lai YL, Kadri SS, Olivier KN, Zelazny A, Prevots DR. Dean SG, et al. Among authors: prevots dr. Emerg Infect Dis. 2020 Sep;26(9):2243-2246. doi: 10.3201/eid2609.200749. Emerg Infect Dis. 2020. PMID: 32818422 Free PMC article.

32

Extrapulmonary Nontuberculous Mycobacteria Infections in Hospitalized Patients, United States, 2009-2014.

Ricotta EE, Adjemian J, Blakney RA, Lai YL, Kadri SS, Prevots DR. Ricotta EE, et al. Among authors: prevots dr. Emerg Infect Dis. 2021 Mar;27(3):845-852. doi: 10.3201/eid2703.201087. Emerg Infect Dis. 2021. PMID: 33622461 Free PMC article.

33

Missing diagnoses of congenital cytomegalovirus infection in electronic health records for infants with laboratory-confirmed infection.

Campione A, Lanzieri TM, Ricotta E, Grosse SD, Kadri SS, Nussenblatt V, Prevots DR. Campione A, et al. Among authors: prevots dr. Curr Med Res Opin. 2022 Feb;38(2):273-275. doi: 10.1080/03007995.2021.2006536. Epub 2021 Dec 6. Curr Med Res Opin. 2022. PMID: 34775876 Free PMC article.

34

Environmental predictors of pulmonary nontuberculous mycobacteria (NTM) sputum positivity among persons with cystic fibrosis in the state of Florida.

Foote SL, Lipner EM, Prevots DR, Ricotta EE. Foote SL, et al. Among authors: prevots dr. PLoS One. 2021 Dec 9;16(12):e0259964. doi: 10.1371/journal.pone.0259964. eCollection 2021. PLoS One. 2021. PMID: 34882686 Free PMC article.

35

Healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (HALT NTM) study: Rationale and study design.

Gross JE, Caceres S, Poch K, Hasan NA, Davidson RM, Epperson LE, Lipner E, Vang C, Honda JR, Strand M, Strong M, Saiman L, Prevots DR, Olivier KN, Nick JA. Gross JE, et al. Among authors: prevots dr. PLoS One. 2021 Dec 20;16(12):e0261628. doi: 10.1371/journal.pone.0261628. eCollection 2021. PLoS One. 2021. PMID: 34929010 Free PMC article.

36

The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohort.

Blakney RA, Ricotta EE, Follmann D, Drew J, Carey KA, Glass LN, Robinson C, MacDonald S, McShane PJ, Olivier KN, Fennelly K, Prevots DR. Blakney RA, et al. Among authors: prevots dr. BMC Infect Dis. 2022 Jan 21;22(1):75. doi: 10.1186/s12879-022-07054-6. BMC Infect Dis. 2022. PMID: 35062891 Free PMC article.

37

HALTing Nontuberculous Mycobacteria in Cystic Fibrosis Centers: Is There Something in the Water?

Olivier KN, Prevots DR. Olivier KN, et al. Among authors: prevots dr. Am J Respir Crit Care Med. 2022 May 1;205(9):982-983. doi: 10.1164/rccm.202202-0337ED. Am J Respir Crit Care Med. 2022. PMID: 35275803 Free PMC article. No abstract available.

38

Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria.

Drummond RA, Desai JV, Ricotta EE, Swamydas M, Deming C, Conlan S, Quinones M, Matei-Rascu V, Sherif L, Lecky D, Lee CR, Green NM, Collins N, Zelazny AM, Prevots DR, Bending D, Withers D, Belkaid Y, Segre JA, Lionakis MS. Drummond RA, et al. Among authors: prevots dr. Cell Host Microbe. 2022 Jul 13;30(7):1020-1033.e6. doi: 10.1016/j.chom.2022.04.013. Epub 2022 May 13. Cell Host Microbe. 2022. PMID: 35568028 Free PMC article.

39

Incidence of Nontuberculous Mycobacterial Pulmonary Infection, by Ethnic Group, Hawaii, USA, 2005-2019.

Blakney RA, Ricotta EE, Frankland TB, Honda S, Zelazny A, Mayer-Barber KD, Dean SG, Follmann D, Olivier KN, Daida YG, Prevots DR. Blakney RA, et al. Among authors: prevots dr. Emerg Infect Dis. 2022 Aug;28(8):1543-1550. doi: 10.3201/eid2808.212375. Emerg Infect Dis. 2022. PMID: 35876462 Free PMC article. Review.

40

Machine Learning in Infectious Disease for Risk Factor Identification and Hypothesis Generation: Proof of Concept Using Invasive Candidiasis.

Mayer LM, Strich JR, Kadri SS, Lionakis MS, Evans NG, Prevots DR, Ricotta EE. Mayer LM, et al. Among authors: prevots dr. Open Forum Infect Dis. 2022 Aug 3;9(8):ofac401. doi: 10.1093/ofid/ofac401. eCollection 2022 Aug. Open Forum Infect Dis. 2022. PMID: 36004317 Free PMC article.

41

The risk of pulmonary NTM infections and water-quality constituents among persons with cystic fibrosis in the United States, 2010-2019.

Lipner EM, French JP, Mercaldo RA, Nelson S, Zelazny AM, Marshall JE, Strong M, Falkinham JO 3rd, Prevots DR. Lipner EM, et al. Among authors: prevots dr. Environ Epidemiol. 2023 Aug 25;7(5):e266. doi: 10.1097/EE9.0000000000000266. eCollection 2023 Oct. Environ Epidemiol. 2023. PMID: 37840858 Free PMC article.

42

Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease.

Adjemian J, Prevots DR, Gallagher J, Heap K, Gupta R, Griffith D. Adjemian J, et al. Among authors: prevots dr. Ann Am Thorac Soc. 2014 Jan;11(1):9-16. doi: 10.1513/AnnalsATS.201304-085OC. Ann Am Thorac Soc. 2014. PMID: 24236749 Free PMC article.

43

Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.

Prevots DR, Marras TK. Prevots DR, et al. Clin Chest Med. 2015 Mar;36(1):13-34. doi: 10.1016/j.ccm.2014.10.002. Epub 2014 Nov 6. Clin Chest Med. 2015. PMID: 25676516 Free PMC article. Review.

44

The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States.

Strollo SE, Adjemian J, Adjemian MK, Prevots DR. Strollo SE, et al. Among authors: prevots dr. Ann Am Thorac Soc. 2015 Oct;12(10):1458-64. doi: 10.1513/AnnalsATS.201503-173OC. Ann Am Thorac Soc. 2015. PMID: 26214350 Free PMC article.

45

Long-Term Outcomes in a Population-based Cohort with Respiratory Nontuberculous Mycobacteria Isolation.

Henkle E, Novosad SA, Shafer S, Hedberg K, Siegel SAR, Ku J, Varley C, Prevots DR, Marras TK, Winthrop KL. Henkle E, et al. Among authors: prevots dr. Ann Am Thorac Soc. 2017 Jul;14(7):1120-1128. doi: 10.1513/AnnalsATS.201610-801OC. Ann Am Thorac Soc. 2017. PMID: 28406709 Free PMC article.

46

Nontuberculous Mycobacterial Disease and Molybdenum in Colorado Watersheds.

Lipner EM, French J, Bern CR, Walton-Day K, Knox D, Strong M, Prevots DR, Crooks JL. Lipner EM, et al. Among authors: prevots dr. Int J Environ Res Public Health. 2020 May 29;17(11):3854. doi: 10.3390/ijerph17113854. Int J Environ Res Public Health. 2020. PMID: 32485845 Free PMC article.

47

Nontuberculous mycobacterial infection and environmental molybdenum in persons with cystic fibrosis: a case-control study in Colorado.

Lipner EM, Crooks JL, French J, Strong M, Nick JA, Prevots DR. Lipner EM, et al. Among authors: prevots dr. J Expo Sci Environ Epidemiol. 2022 Mar;32(2):289-294. doi: 10.1038/s41370-021-00360-2. Epub 2021 Jul 3. J Expo Sci Environ Epidemiol. 2022. PMID: 34218259 Free PMC article.

48

Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease.

Prevots DR, Marras TK, Wang P, Mange KC, Flume PA. Prevots DR, et al. Chest. 2021 Dec;160(6):2042-2050. doi: 10.1016/j.chest.2021.07.034. Epub 2021 Jul 24. Chest. 2021. PMID: 34314672 Free PMC article.

49

Nontuberculous Mycobacteria Infection Risk and Trace Metals in Surface Water: A Population-based Ecologic Epidemiologic Study in Oregon.

Lipner EM, French JP, Falkinham JO 3rd, Crooks JL, Mercaldo RA, Henkle E, Prevots DR. Lipner EM, et al. Among authors: prevots dr. Ann Am Thorac Soc. 2022 Apr;19(4):543-550. doi: 10.1513/AnnalsATS.202101-053OC. Ann Am Thorac Soc. 2022. PMID: 34582742 Free PMC article.

50

Vanadium in groundwater aquifers increases the risk of MAC pulmonary infection in O'ahu, Hawai'i.

Lipner EM, French JP, Nelson S, Falkinham Iii JO, Mercaldo RA, Blakney RA, Daida YG, Frankland TB, Messier KP, Honda JR, Honda S, Prevots DR. Lipner EM, et al. Among authors: prevots dr. Environ Epidemiol. 2022 Sep 2;6(5):e220. doi: 10.1097/EE9.0000000000000220. eCollection 2022 Oct. Environ Epidemiol. 2022. PMID: 36249270 Free PMC article.

51

Nontuberculous mycobacterial pulmonary disease: an increasing burden with substantial costs.

Prevots DR, Loddenkemper R, Sotgiu G, Migliori GB. Prevots DR, et al. Eur Respir J. 2017 Apr 26;49(4):1700374. doi: 10.1183/13993003.00374-2017. Print 2017 Apr. Eur Respir J. 2017. PMID: 28446563 Free PMC article. No abstract available.

52

Estimating vaccine effectiveness against SARS-CoV-2 infection, hospitalization and death from ecologic data in Costa Rica.

Fantin R, Herrero R, Hildesheim A, Barboza-Solís C, Aparicio A, Prevots DR, Pfeiffer RM, Gail MH; RESPIRA Study Group. Fantin R, et al. Among authors: prevots dr. BMC Infect Dis. 2022 Oct 2;22(1):767. doi: 10.1186/s12879-022-07740-5. BMC Infect Dis. 2022. PMID: 36184587 Free PMC article.

53

Seroepidemiology of helminths and the association with severe malaria among infants and young children in Tanzania.

Kwan JL, Seitz AE, Fried M, Lee KL, Metenou S, Morrison R, Kabyemela E, Nutman TB, Prevots DR, Duffy PE. Kwan JL, et al. Among authors: prevots dr. PLoS Negl Trop Dis. 2018 Mar 26;12(3):e0006345. doi: 10.1371/journal.pntd.0006345. eCollection 2018 Mar. PLoS Negl Trop Dis. 2018. PMID: 29579050 Free PMC article.

54

Tenets of a holistic approach to drinking water-associated pathogen research, management, and communication.

Proctor C, Garner E, Hamilton KA, Ashbolt NJ, Caverly LJ, Falkinham JO 3rd, Haas CN, Prevost M, Prevots DR, Pruden A, Raskin L, Stout J, Haig SJ. Proctor C, et al. Among authors: prevots dr. Water Res. 2022 Mar 1;211:117997. doi: 10.1016/j.watres.2021.117997. Epub 2021 Dec 22. Water Res. 2022. PMID: 34999316 Free PMC article. Review.

55

Behavioral factors and SARS-CoV-2 transmission heterogeneity within a household cohort in Costa Rica.

Sun K, Loria V, Aparicio A, Porras C, Vanegas JC, Zúñiga M, Morera M, Avila C, Abdelnour A, Gail MH, Pfeiffer R, Cohen JI, Burbelo PD, Abed MA, Viboud C, Hildesheim A, Herrero R, Prevots DR; RESPIRA Study Group. Sun K, et al. Among authors: prevots dr. Commun Med (Lond). 2023 Jul 22;3(1):102. doi: 10.1038/s43856-023-00325-6. Commun Med (Lond). 2023. PMID: 37481623 Free PMC article.

56

Burden of congenital rubella syndrome after a community-wide rubella outbreak, Rio Branco, Acre, Brazil, 2000 to 2001.

Lanzieri TM, Segatto TC, Siqueira MM, de Oliviera Santos EC, Jin L, Prevots DR. Lanzieri TM, et al. Among authors: prevots dr. Pediatr Infect Dis J. 2003 Apr;22(4):323-9. doi: 10.1097/01.inf.0000059401.07698.95. Pediatr Infect Dis J. 2003. PMID: 12690271

57

Incidence, clinical features and estimated costs of congenital rubella syndrome after a large rubella outbreak in Recife, Brazil, 1999-2000.

Lanzieri TM, Parise MS, Siqueira MM, Fortaleza BM, Segatto TC, Prevots DR. Lanzieri TM, et al. Among authors: prevots dr. Pediatr Infect Dis J. 2004 Dec;23(12):1116-22. Pediatr Infect Dis J. 2004. PMID: 15626948

58

Impact of rubella vaccination strategy on the occurrence of congenital rubella syndrome.

Lanzieri TM, Pinto D, Prevots DR. Lanzieri TM, et al. Among authors: prevots dr. J Pediatr (Rio J). 2007 Sep-Oct;83(5):415-21. doi: 10.2223/JPED.1692. Epub 2007 Sep 13. J Pediatr (Rio J). 2007. PMID: 17853958

59

Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital.

Jeon CY, Hwang SH, Min JH, Prevots DR, Goldfeder LC, Lee H, Eum SY, Jeon DS, Kang HS, Kim JH, Kim BJ, Kim DY, Holland SM, Park SK, Cho SN, Barry CE 3rd, Via LE. Jeon CY, et al. Among authors: prevots dr. Clin Infect Dis. 2008 Jan 1;46(1):42-9. doi: 10.1086/524017. Clin Infect Dis. 2008. PMID: 18171212 Free article.

60

Hospitalizations associated with disseminated coccidioidomycosis, Arizona and California, USA.

Seitz AE, Prevots DR, Holland SM. Seitz AE, et al. Among authors: prevots dr. Emerg Infect Dis. 2012 Sep;18(9):1476-9. doi: 10.3201/eid1809.120151. Emerg Infect Dis. 2012. PMID: 22931562 Free PMC article.

61

Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011.

de Mello KG, Mello FC, Borga L, Rolla V, Duarte RS, Sampaio EP, Holland SM, Prevots DR, Dalcolmo MP. de Mello KG, et al. Among authors: prevots dr. Emerg Infect Dis. 2013 Mar;19(3):393-9. doi: 10.3201/eid/1903.120735. Emerg Infect Dis. 2013. PMID: 23745217 Free PMC article.

62

Incidence and trends of blastomycosis-associated hospitalizations in the United States.

Seitz AE, Younes N, Steiner CA, Prevots DR. Seitz AE, et al. Among authors: prevots dr. PLoS One. 2014 Aug 15;9(8):e105466. doi: 10.1371/journal.pone.0105466. eCollection 2014. PLoS One. 2014. PMID: 25126839 Free PMC article.

63

Spatial epidemiology of blastomycosis hospitalizations: detecting clusters and identifying environmental risk factors.

Seitz AE, Adjemian J, Steiner CA, Prevots DR. Seitz AE, et al. Among authors: prevots dr. Med Mycol. 2015 Jun;53(5):447-54. doi: 10.1093/mmy/myv014. Epub 2015 Apr 23. Med Mycol. 2015. PMID: 25908653 Free PMC article.

64

Long-term Follow-up of Patients With Lyme Disease: Longitudinal Analysis of Clinical and Quality-of-life Measures.

Wills AB, Spaulding AB, Adjemian J, Prevots DR, Turk SP, Williams C, Marques A. Wills AB, et al. Among authors: prevots dr. Clin Infect Dis. 2016 Jun 15;62(12):1546-1551. doi: 10.1093/cid/ciw189. Epub 2016 Mar 29. Clin Infect Dis. 2016. PMID: 27025825 Free PMC article.

65

Epidemiology of Norovirus Infection Among Immunocompromised Patients at a Tertiary Care Research Hospital, 2010-2013.

Bok K, Prevots DR, Binder AM, Parra GI, Strollo S, Fahle GA, Behrle-Yardley A, Johnson JA, Levenson EA, Sosnovtsev SV, Holland SM, Palmore TN, Green KY. Bok K, et al. Among authors: prevots dr. Open Forum Infect Dis. 2016 Sep 8;3(3):ofw169. doi: 10.1093/ofid/ofw169. eCollection 2016 Sep. Open Forum Infect Dis. 2016. PMID: 27800529 Free PMC article.

66

Epidemiology of Hospitalizations Associated with Invasive Candidiasis, United States, 2002-2012¹.

Strollo S, Lionakis MS, Adjemian J, Steiner CA, Prevots DR. Strollo S, et al. Among authors: prevots dr. Emerg Infect Dis. 2016 Jan;23(1):7-13. doi: 10.3201/eid2301.161198. Emerg Infect Dis. 2016. PMID: 27983497 Free PMC article.

67

Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases.

van Ingen J, Wagner D, Gallagher J, Morimoto K, Lange C, Haworth CS, Floto RA, Adjemian J, Prevots DR, Griffith DE; NTM-NET. van Ingen J, et al. Among authors: prevots dr. Eur Respir J. 2017 Feb 15;49(2):1601855. doi: 10.1183/13993003.01855-2016. Print 2017 Feb. Eur Respir J. 2017. PMID: 28182571 Free article. No abstract available.

68

Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination.

Prevots DR, Ciofi degli Atti ML, Sallabanda A, Diamante E, Aylward RB, Kakariqqi E, Fiore L, Ylli A, van der Avoort H, Sutter RW, Tozzi AE, Panei P, Schinaia N, Genovese D, Oblapenko G, Greco D, Wassilak SG. Prevots DR, et al. Clin Infect Dis. 1998 Feb;26(2):419-25. doi: 10.1086/516312. Clin Infect Dis. 1998. PMID: 9502465

69

Interruption of measles transmission in Brazil, 2000-2001.

Prevots DR, Parise MS, Segatto TC, Siqueira MM, dos Santos ED, Ganter B, Perreira MC, Domingues CA, Lanzieri T, Da Silva JB Jr. Prevots DR, et al. J Infect Dis. 2003 May 15;187 Suppl 1:S111-20. doi: 10.1086/368030. J Infect Dis. 2003. PMID: 12721901 Review.

70

Coincident filarial, intestinal helminth, and mycobacterial infection: helminths fail to influence tuberculin reactivity, but BCG influences hookworm prevalence.

Lipner EM, Gopi PG, Subramani R, Kolappan C, Sadacharam K, Kumaran P, Prevots DR, Narayanan PR, Nutman TB, Kumaraswami V. Lipner EM, et al. Among authors: prevots dr. Am J Trop Med Hyg. 2006 May;74(5):841-7. Am J Trop Med Hyg. 2006. PMID: 16687690

71

Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity.

Lipner EM, Dembele N, Souleymane S, Alley WS, Prevots DR, Toe L, Boatin B, Weil GJ, Nutman TB. Lipner EM, et al. Among authors: prevots dr. J Infect Dis. 2006 Jul 15;194(2):216-21. doi: 10.1086/505081. Epub 2006 Jun 14. J Infect Dis. 2006. PMID: 16779728

72

Filariasis in travelers presenting to the GeoSentinel Surveillance Network.

Lipner EM, Law MA, Barnett E, Keystone JS, von Sonnenburg F, Loutan L, Prevots DR, Klion AD, Nutman TB; GeoSentinel Surveillance Network. Lipner EM, et al. Among authors: prevots dr. PLoS Negl Trop Dis. 2007 Dec 26;1(3):e88. doi: 10.1371/journal.pntd.0000088. PLoS Negl Trop Dis. 2007. PMID: 18160987 Free PMC article.

73

Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil.

de Filippis I, de Lemos AP, Hostetler JB, Wollenberg K, Sacchi CT, Dunning Hotopp JC, Harrison LH, Bash MC, Prevots DR. de Filippis I, et al. Among authors: prevots dr. PLoS One. 2012;7(3):e33016. doi: 10.1371/journal.pone.0033016. Epub 2012 Mar 14. PLoS One. 2012. PMID: 22431994 Free PMC article.

74

Epidemiology of cryptococcal meningitis in the US: 1997-2009.

Pyrgos V, Seitz AE, Steiner CA, Prevots DR, Williamson PR. Pyrgos V, et al. Among authors: prevots dr. PLoS One. 2013;8(2):e56269. doi: 10.1371/journal.pone.0056269. Epub 2013 Feb 15. PLoS One. 2013. PMID: 23457543 Free PMC article.

75

Parasite burden and severity of malaria in Tanzanian children.

Gonçalves BP, Huang CY, Morrison R, Holte S, Kabyemela E, Prevots DR, Fried M, Duffy PE. Gonçalves BP, et al. Among authors: prevots dr. N Engl J Med. 2014 May 8;370(19):1799-808. doi: 10.1056/NEJMoa1303944. N Engl J Med. 2014. PMID: 24806160 Free PMC article.

76

Variable agreement among experts regarding Mycobacterium avium complex lung disease.

Marras TK, Prevots DR, Jamieson FB, Winthrop KL; Pulmonary MAC Outcomes Group. Marras TK, et al. Among authors: prevots dr. Respirology. 2015 Feb;20(2):348-51. doi: 10.1111/resp.12440. Epub 2014 Nov 28. Respirology. 2015. PMID: 25430584 Free PMC article.

77

Hemoglobin variants shape the distribution of malaria parasites in human populations and their transmission potential.

Gonçalves BP, Sagara I, Coulibaly M, Wu Y, Assadou MH, Guindo A, Ellis RD, Diakite M, Gabriel E, Prevots DR, Doumbo OK, Duffy PE. Gonçalves BP, et al. Among authors: prevots dr. Sci Rep. 2017 Oct 27;7(1):14267. doi: 10.1038/s41598-017-14627-y. Sci Rep. 2017. PMID: 29079846 Free PMC article.

78

Norovirus, astrovirus, and sapovirus among immunocompromised patients at a tertiary care research hospital.

Daniel-Wayman S, Fahle G, Palmore T, Green KY, Prevots DR. Daniel-Wayman S, et al. Among authors: prevots dr. Diagn Microbiol Infect Dis. 2018 Oct;92(2):143-146. doi: 10.1016/j.diagmicrobio.2018.05.017. Epub 2018 May 29. Diagn Microbiol Infect Dis. 2018. PMID: 29934072 Free PMC article.

79

Nontuberculous mycobacterial pulmonary disease incidence among elderly patients with bronchiectasis.

Schildknecht K, Winthrop KL, Prevots DR, Blakney R, Henkle E. Schildknecht K, et al. Among authors: prevots dr. Eur Respir J. 2022 Jun 23;59(6):2200018. doi: 10.1183/13993003.00018-2022. Print 2022 Jun. Eur Respir J. 2022. PMID: 35361629 Free article. No abstract available.

80

Assessment of Guillain-Barré syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance.

Prevots DR, Sutter RW. Prevots DR, et al. J Infect Dis. 1997 Feb;175 Suppl 1:S151-5. doi: 10.1093/infdis/175.supplement_1.s151. J Infect Dis. 1997. PMID: 9203708

81

Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient.

Kew OM, Sutter RW, Nottay BK, McDonough MJ, Prevots DR, Quick L, Pallansch MA. Kew OM, et al. Among authors: prevots dr. J Clin Microbiol. 1998 Oct;36(10):2893-9. doi: 10.1128/JCM.36.10.2893-2899.1998. J Clin Microbiol. 1998. PMID: 9738040 Free PMC article.

82

Opinions differ by expertise in Mycobacterium avium complex disease.

Marras TK, Prevots DR, Jamieson FB, Winthrop KL; Pulmonary MAC Outcomes Group. Marras TK, et al. Among authors: prevots dr. Ann Am Thorac Soc. 2014 Jan;11(1):17-22. doi: 10.1513/AnnalsATS.201305-136OC. Ann Am Thorac Soc. 2014. PMID: 24083335 Free PMC article.

83

Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.

Khetsuriani N, Prevots DR, Quick L, Elder ME, Pallansch M, Kew O, Sutter RW. Khetsuriani N, et al. Among authors: prevots dr. J Infect Dis. 2003 Dec 15;188(12):1845-52. doi: 10.1086/379791. Epub 2003 Dec 8. J Infect Dis. 2003. PMID: 14673763

84

Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).

Prevots DR, Burr RK, Sutter RW, Murphy TV; Advisory Committee on Immunization Practices. Prevots DR, et al. MMWR Recomm Rep. 2000 May 9;49(RR-5):1-22; quiz CE1-7. MMWR Recomm Rep. 2000. PMID: 15580728 Free article.

85

Preparing for future efficacy trials of severe malaria vaccines.

Gonçalves BP, Prevots DR, Kabyemela E, Fried M, Duffy PE. Gonçalves BP, et al. Among authors: prevots dr. Vaccine. 2016 Apr 7;34(16):1865-7. doi: 10.1016/j.vaccine.2016.02.053. Epub 2016 Mar 8. Vaccine. 2016. PMID: 26923455 Free PMC article.

86

A Malaria-Resistant Phenotype with Immunological Correlates in a Tanzanian Birth Cohort Exposed to Intense Malaria Transmission.

Nash SD, Prevots DR, Kabyemela E, Khasa YP, Lee KL, Fried M, Duffy PE. Nash SD, et al. Among authors: prevots dr. Am J Trop Med Hyg. 2017 May;96(5):1190-1196. doi: 10.4269/ajtmh.16-0554. Am J Trop Med Hyg. 2017. PMID: 28500801 Free PMC article.

87

First reported outbreak of classical dengue fever at 1,700 meters above sea level in Guerrero State, Mexico, June 1988.

Herrera-Basto E, Prevots DR, Zarate ML, Silva JL, Sepulveda-Amor J. Herrera-Basto E, et al. Among authors: prevots dr. Am J Trop Med Hyg. 1992 Jun;46(6):649-53. doi: 10.4269/ajtmh.1992.46.649. Am J Trop Med Hyg. 1992. PMID: 1621889

88

Determinants and predictors of dengue infection in Mexico.

Koopman JS, Prevots DR, Vaca Marin MA, Gomez Dantes H, Zarate Aquino ML, Longini IM Jr, Sepulveda Amor J. Koopman JS, et al. Among authors: prevots dr. Am J Epidemiol. 1991 Jun 1;133(11):1168-78. doi: 10.1093/oxfordjournals.aje.a115829. Am J Epidemiol. 1991. PMID: 2035520

89

Tetanus surveillance--United States, 1991-1994.

Izurieta HS, Sutter RW, Strebel PM, Bardenheier B, Prevots DR, Wharton M, Hadler SC. Izurieta HS, et al. Among authors: prevots dr. MMWR CDC Surveill Summ. 1997 Feb 21;46(2):15-25. MMWR CDC Surveill Summ. 1997. PMID: 12412769 Free article.

90

Population immunity to polioviruses among preschool children from four urban underserved low income communities, United States, 1997-2001.

Prevots DR, Pascual FB, Angellili ML, Brayden R, Irigoyen M, Larussa P, Sawyer M, Baughman AL, Pallansch MA. Prevots DR, et al. Pediatr Infect Dis J. 2004 Dec;23(12):1130-6. Pediatr Infect Dis J. 2004. PMID: 15626951

91

Cytokine profiles at birth predict malaria severity during infancy.

Kabyemela E, Gonçalves BP, Prevots DR, Morrison R, Harrington W, Gwamaka M, Kurtis JD, Fried M, Duffy PE. Kabyemela E, et al. Among authors: prevots dr. PLoS One. 2013 Oct 10;8(10):e77214. doi: 10.1371/journal.pone.0077214. eCollection 2013. PLoS One. 2013. PMID: 24130857 Free PMC article.

92

Tetanus surveillance--United States, 1995-1997.

Bardenheier B, Prevots DR, Khetsuriani N, Wharton M. Bardenheier B, et al. Among authors: prevots dr. MMWR CDC Surveill Summ. 1998 Jul 3;47(2):1-13. MMWR CDC Surveill Summ. 1998. PMID: 9665156 Free article.

93

Pertussis outbreak in an elementary school with high vaccination coverage.

Khetsuriani N, Bisgard K, Prevots DR, Brennan M, Wharton M, Pandya S, Poppe A, Flora K, Dameron G, Quinlisk P. Khetsuriani N, et al. Among authors: prevots dr. Pediatr Infect Dis J. 2001 Dec;20(12):1108-12. doi: 10.1097/00006454-200112000-00003. Pediatr Infect Dis J. 2001. PMID: 11740314

94

The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997.

da Silveira CM, Kmetzsch CI, Mohrdieck R, Sperb AF, Prevots DR. da Silveira CM, et al. Among authors: prevots dr. Int J Epidemiol. 2002 Oct;31(5):978-82. doi: 10.1093/ije/31.5.978. Int J Epidemiol. 2002. PMID: 12435771

95

Impact of the sequential poliovirus immunization schedule: a demonstration project.

Kolasa MS, Desai SN, Bisgard KM, Dibling K, Prevots DR. Kolasa MS, et al. Among authors: prevots dr. Am J Prev Med. 2000 Feb;18(2):140-5. doi: 10.1016/s0749-3797(99)00132-4. Am J Prev Med. 2000. PMID: 10698244

96

Neonatal tetanus incidence in China, 1996-2001, and risk factors for neonatal tetanus, Guangxi Province, China.

Chai F, Prevots DR, Wang X, Birmingham M, Zhang R. Chai F, et al. Among authors: prevots dr. Int J Epidemiol. 2004 Jun;33(3):551-7. doi: 10.1093/ije/dyh073. Epub 2004 May 20. Int J Epidemiol. 2004. PMID: 15155708

97

Vaccine policy changes and epidemiology of poliomyelitis in the United States.

Alexander LN, Seward JF, Santibanez TA, Pallansch MA, Kew OM, Prevots DR, Strebel PM, Cono J, Wharton M, Orenstein WA, Sutter RW. Alexander LN, et al. Among authors: prevots dr. JAMA. 2004 Oct 13;292(14):1696-701. doi: 10.1001/jama.292.14.1696. JAMA. 2004. PMID: 15479934

98

PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004.

de Filippis I, de Andrade CF, Silva L, Prevots DR, Vicente AC. de Filippis I, et al. Among authors: prevots dr. Infect Immun. 2007 Jul;75(7):3683-5. doi: 10.1128/IAI.01721-06. Epub 2007 May 14. Infect Immun. 2007. PMID: 17502397 Free PMC article.

99

Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease.

Prevots DR, Sutter RW, Strebel PM, Weibel RE, Cochi SL. Prevots DR, et al. Arch Pediatr Adolesc Med. 1994 May;148(5):479-85. doi: 10.1001/archpedi.1994.02170050037007. Arch Pediatr Adolesc Med. 1994. PMID: 8180638

100

Poliomyelitis prevention in the United States: new recommendations for routine childhood vaccination place greater reliance on inactivated poliovirus vaccine.

Prevots DR, Strebel PM. Prevots DR, et al. Pediatr Ann. 1997 Jun;26(6):378-83. doi: 10.3928/0090-4481-19970601-09. Pediatr Ann. 1997. PMID: 9188130 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page